CPA3 and chronic obstructive pulmonary disease: Our approach for histology-based quantitative analysis of CPA3 expression patterns in individual tissue cells revealed that mast cells in COPD lungs had significant increased CPA3 mRNA expression across the distal lung compartments compared to non-diseased control lungs (Figure 1A).